Access cutting-edge advanced cancer treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access advanced cancer specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced cancer treatment provided free
This is a 2-part, phase 1/2, open-label, multicenter study designed to evaluate the safety, tolerability, PK, pharmacodynamics, PGx, and efficacy of fadraciclib administered orally BID. This study consists of Phase 1 and Phase 2 components in subjects with advanced solid tumors and lymphoma who have progressed despite having standard therapy or for which no standard therapy exists.
Sponsor: Cyclacel Pharmaceuticals, Inc.
Check if you qualify for this advanced cancer clinical trial in Houston, TX
If you're searching for advanced cancer treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.